Myriad Genetics, Inc. (NASDAQ:MYGN) stock position cut by Earnest Partners LLC
Earnest Partners LLC cut its position in Myriad Genetics, Inc. (NASDAQ: MYGN – Get Rating) by 49.7% during the 4th quarter, according to the company in its latest filing with…